EP
EPZM

Eversept Partners’s Epizyme, Inc EPZM Stock Holding History

Eversept Partners’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25,449
Closed -$157K – 68
2018
Q4 		$157K Sell
25,449
-22,000
-46% -$168K 0.08% 53
2018
Q3 		$503K Hold
47,449
– – 0.22% 50
2018
Q2 		$643K Sell
47,449
-10,000
-17% -$156K 0.29% 51
2018
Q1 		$1.02M Buy
+57,449
New +$970K 0.47% 37

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Eversept Partners's EPZM Position: Q1 2019 in Review

Eversept Partners sold out of Epizyme, Inc (EPZM) in Q1 2019, closing a stake of 25,449 shares — an estimated $157K sold.

Eversept Partners first reported a position in EPZM in Q1 2018 and held it in 4 quarters. The position peaked at $1.02M in Q1 2018. 121 funds tracked by Wall St. Rank hold EPZM as of Q1 2019.

  • Eversept Partners reported no remaining Epizyme, Inc position as of Q1 2019 after selling out during the quarter.
  • Eversept Partners sold 25,449 Epizyme, Inc shares in Q1 2019, an estimated $157K.
  • Eversept Partners first reported a position in Epizyme, Inc in Q1 2018 and held it in 4 quarters.
  • Eversept Partners's Epizyme, Inc position peaked at $1.02M in Q1 2018.
  • 121 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2019.

Based on Eversept Partners's 13F filing for Q1 2019, filed 14 May 2019.